<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Among the biological assays used for the diagnosis of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), the detection of anti-double strand DNA antibodies (dsDNA Ab) is regarded as highly specific </plain></SENT>
<SENT sid="1" pm="."><plain>However this biological parameter is negative among 20 to 40% of patients </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies have revealed potential interest of the anti-nucleosome antibodies in the diagnosis of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, in particular when any anti-dsDNA antibody activity could be detected </plain></SENT>
<SENT sid="3" pm="."><plain>We selected 80 sera in order to evaluate four commercial anti-nucleosome enzyme-based immunoassays (EIA) kits </plain></SENT>
<SENT sid="4" pm="."><plain>Their sensitivity and specificity values were compared with those obtained by the detection of anti-dsDNA Ab, carried out with both a Farr assay and two EIA kits </plain></SENT>
<SENT sid="5" pm="."><plain>No anti-nucleosome EIA kits reached performances of the Farr assay for the diagnosis of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>On the other hand, our results show an higher diagnostic value for some anti-nucleosome EIA kits compared with 2 anti-dsDNA EIA kits </plain></SENT>
<SENT sid="7" pm="."><plain>Apart from SLE, anti-nucleosome antibodies can be observed in others auto-<z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune diseases</z:e>, in particular <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndromes</z:e>, the <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e>, the systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> and the <z:e sem="disease" ids="C0026272" disease_type="Disease or Syndrome" abbrv="MCTD">mixed connective tissue disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Compared results of the four anti-nucleosome EIA kits highlight many discordances </plain></SENT>
<SENT sid="9" pm="."><plain>These variations, testifying to the absence of standardization for this new parameter, must encourage with a careful interpretation of results, according to the clinical context </plain></SENT>
</text></document>